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Summary
Previously, we demonstrated evidence of linkage to bi-
polar affective disorder (BP) in a single large, multige-
nerational family with a LOD score of 3.41 at the PFKL
locus on chromosome 21q22.3. Additional families
showed little support for linkage to PFKL under ho-
mogeneity or heterogeneity, in that study. We have ex-
panded on that analysis, with 31 microsatellite markers
at an average marker spacing of 2 cM, in the largest
multigenerational BP pedigree series reported to date. A
two-point heterogeneity ( ) LOD score of 3.35a  0.5
( ) was found at the D21S1260 locus, 5 cMP ! .000156
proximal to PFKL. Polylocus analysis with a cluster of
three neighboring markers was consistent with these re-
sults (PL-HetLOD  3.25). In the design of this study,
373 individuals from 40 families (from a total set of
1,508 individuals in 57 families) were chosen, as a cost-
effective approach to genotyping this large sample set.
Linkage analyses were performed with an “affecteds-
only” method. As such, our results are based solely on
genetic information from affected individuals, without
assumptions about the disease-locus genotypes of the
unaffecteds. Furthermore, for ease of comparison, this
study was performed with the same approach as a 10-
cM genome scan for BP loci, the results of which will
be reported elsewhere.
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Introduction
Bipolar affective disorder (BP), or manic-depressive ill-
ness, is a severe and common psychiatric disorder with
a lifetime prevalence of 0.5%–1.5%. An estimated
20%–25% of patients commit suicide, giving BP a mor-
tality rate higher than that of many types of heart disease
and cancer (Goodwin and Jamison 1990).
Family, twin, and adoption studies strongly implicate
a discernable role for genetics in the etiology of BP, but
no genes have been identified conclusively. One chro-
mosomal region identified as possibly harboring a locus
for susceptibility to BP is 21q22. Prompted by an initial
report from our group (Straub et al. 1994), several lab-
oratories have investigated linkage of BP to 21q22. De-
tera-Wadleigh et al. (1996) observed an excess of allele
sharing among affected individuals at nine 21q loci span-
ning distal 21q. More recently, support for linkage to
21q was reported in the National Institute of Mental
Health (NIMH) Genetics Initiative Bipolar Study (De-
tera-Wadleigh et al. 1997), with multilocus affected sib-
pair analyses indicating excess allele sharing in the
D21S1265–D21S1255 region. Smyth et al. (1997) re-
ported a “suggestive” multipoint LOD score of 1.29,
using the markers PFKL and D21S171; this score in-
creased to 3.87 under a two-locus admixture model of
PFKL/D21S171 and the tyrosine hydroxylase locus (on
11p15). A detailed review of studies in this area has been
published (Baron 1997), and a synopsis of current link-
age studies on chromosome 21 has been compiled as
part of the Fifth World Congress of Psychiatric Genetics
(Gurling 1998).
We previously reported evidence for linkage to BP on
21q22 based primarily on a single large, multigenera-
tional pedigree (family 01001) with a two-point LOD
score of 3.41 at the PFKL locus (Straub et al. 1994). At
the time, 46 additional families were tested with two
markers, PFKL and the more distal marker, D21S171,
without significant evidence for linkage. However, we
found modest evidence ( ) at PFKL, using theP ! .0003
affected-pedigree-member method. Here we report evi-
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dence for the presence of a putative BP locus on 21q22,
based on an analysis of 31 highly polymorphic micro-
satellite markers, including a concentration of 27 mark-
ers spanning the most distal 30 cM of the chromosome.
These markers were tested on 373 individuals, 307 of
whom are affected, who provide the bulk of the power
to detect linkage in this sample set.
Material and Methods
Pedigrees, Clinical Classification, and Selection of
Samples for Genotyping
A full description of the pedigree set, including as-
certainment, diagnostic procedures, and power calcu-
lations, has been published (Baron et al. 1994). The over-
all sample consists of 1,508 individuals, from 57
extended pedigrees with a high density of BP, from the
United States (39 pedigrees) and Israel (18 pedigrees).
The study was approved by the Columbia Univer-
sity–New York State Psychiatric Institute Review Board.
Informed consent was obtained from all participants.
Affected individuals were placed into one of three di-
agnostic models, which were devised on the basis of the
research diagnostic criteria classification of affective dis-
orders (Spitzer et al. 1978). All field interviews followed
the Lifetime Version of the Schedule for Affective Dis-
orders and Schizophrenia modified for BP (Endicott and
Spitzer 1978) and were supplemented by family history
information (Andreasen et al. 1977) and medical re-
cords. Best-estimate consensus diagnoses were made by
independent diagnosticians using all available sources of
information and were blinded to familial relationships,
clinical status of other relatives, and genetic data. The
diagnostic models are as follows: model I: bipolar I dis-
order, unipolar manic disorder, bipolar and manic forms
of schizoaffective disorder; model II: model I plus bipolar
II disorder with major depression; and model III: model
II plus recurrent unipolar major depressive disorder and
recurrent unipolar schizoaffective disorder (depression
only).
For the sake of efficiency, a subset of this sample was
chosen for genotyping. The subset consisted of 373 in-
dividuals from the 40 most informative families (an av-
erage of 7 or 8 affected individuals per pedigree), pro-
viding the bulk of the power to detect linkage in the
entire pedigree sample. They were the same individuals
used in a systematic genomewide screen for bipolar loci,
described elsewhere (Liu et al. 1997; J. Liu, V. M. Aita,
J. Terwilliger, T. C. Gilliam, and M. Baron, unpublished
data), as well as other candidate regions for BP (Aita et
al. 1997). They were selected on the basis of a com-
puterized algorithm described by J. Liu, V. M. Aita, J.
Terwilliger, T. C. Gilliam, and M. Baron (unpublished
data), and they contribute most of the genetic infor-
mation available in the sample set (for dominantly in-
herited alleles). The algorithm selected affected individ-
uals and connecting lineal pedigree members while
excluding married-in spouses. It has been shown pre-
viously (Holmans and Craddock 1997) that genotyping
can be made more efficient by excluding founders or
married-in spouses.
Genotyping
DNA was extracted from blood and lymphoblastoid
cell lines by established standard methods (Sambrook et
al. 1989). A semiautomated high-throughput geno-
typing approach using fluorescence-labeled microsatel-
lite markers was performed. All DNA samples and PCR
reagents were pipetted with a TECAN Genesis RSP 150
robotic workstation. DNA was amplified by PCR with
PTC 225 thermocyclers (MJ Research). For all markers,
the last nucleotide of the reverse, nonfluorescent primer
was modified to a guanine (G) residue to promote the
nontemplated addition of adenine by Taq DNA poly-
merase onto the complementary, fluorescence-labeled
strand. This method has been described to consistently
shift the allelic profile of PCR products toward the allele-
plus-A, which allows for more-accurate allele calling
(Magnuson et al. 1996). PCR products were electro-
phoresed on 377 DNA sequencers (PE Applied Bio-
systems).
Generation of genotypes followed a strategy for anal-
ysis of large-scale, fluorescence-labeled genotyping data
described elsewhere (Ghosh et al. 1997). In brief, raw
data were collected by PRISM 377XL data collection
software (PE Applied Biosystems) and sized by GENE-
SCAN version 2.1; alleles were initially called by GENO-
TYPER v.1.1.1. The computer-generated genotypes were
then checked by two independent researchers; any con-
flicts were resolved by a third. These manually inspected
genotypes were then entered into a database, alleles were
binned and labeled, Mendelization checks were per-
formed, and linkage output files were generated by LAB-
MAN (Adams 1994). Marker heterozygosity and poly-
morphism information content (PIC) were estimated by
DOWNFREQ (Terwilliger 1995). Genotypes were de-
termined with the researchers blinded to disease pheno-
types.
Linkage Analysis
A pseudomarker strategy that approximates “model-
free” affected relative pair analysis was used (Trembath
et al. 1997; J. D. Terwilliger and H. H. Goring, unpub-
lished data). This analytical method also maintains an
important property of LOD score analysis—namely, that
pedigree correlations between all relatives are considered
jointly, and the pedigree is not broken into a set of all
possible relative pairs, which are not in reality indepen-
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Figure 1 Two-point LOD scores in diagnostic model III, dominant inheritance. Regions shown are (a) implicated by Detera-Wadleigh
et al. (1997); (b) implicated by Detera-Wadleigh et al. (1996); (c) implicated by Straub et al. (1994); (d) implicated by Smyth et al. (1997); (e)
Down syndrome critical region from Osoegawa et al. (1996); and (f) mapped by Lapenta et al. (1998).
dent of each other. If there is a disease susceptibility allele
that is shared identical by descent (IBD) by all affected
individuals in a given pedigree, then it must have been
transmitted along a single pathway within the pedi-
gree—the individuals along this pathway are exactly the
subset of individuals genotyped in this study, as de-
scribed above. A LOD score analysis can be done be-
tween a “pseudomarker” locus (representing the maxi-
mal possible IBD sharing among affecteds) and the
marker loci genotyped. As has been shown elsewhere
(Trembath et al. 1997; J. D. Terwilliger and H. H. Gor-
ing, unpublished data), this strategy is a robust and pow-
erful analogue of “model-free” linkage analysis in which
all meioses are considered to be independent and iden-
tically distributed with respect to the segregation of the
trait locus.
Two-point LOD scores were computed by means of
the MLINK program from the LINKAGE package (La-
throp et al. 1984). Polylocus LOD scores were computed
by POLYLOCUS from the ANALYZE package (Terwil-
liger 1994). Marker allele frequencies for linkage anal-
yses were estimated on the basis of this data set by LAB-
MAN (Adams 1994). Tests for heterogeneity (Smith
1961) were performed by the HOMOG program (Ott
1991). Affected sibpair analysis was performed by SIB-
PAIR from the ANALYZE package (Kuokkanen et al.
1996; Satsangi et al. 1996). For the sake of analytical
completeness and comparison with other bipolar linkage
studies, analyses were performed with dominant and re-
cessive modes of inheritance, and whole families were
broken into nuclear families. In addition, all analyses
were performed with all three diagnostic models.
Results
We analyzed chromosome 21 with 31 markers, fo-
cusing 27 markers on the most distal 30 cM of 21q. The
LOD scores from two-point pseudomarker analysis
(Trembath et al. 1997; J. D. Terwilliger and H. H. Gor-
ing, unpublished data) under diagnostic model III and
a dominant mode of inheritance are graphed in figure
1. Also shown are regions significant to the study of BP
on chromosome 21 (fig. 1). In this study, the maximum
two-point LOD score (Zmax) is found at D21S1260, with
, assuming locus homogeneity, andZ  2.76 Z max max
, assuming locus heterogeneity ( ) (table 1).3.35 a  0.5
As with any other LOD score reported under the as-
sumption of heterogeneity, the extra degree of freedom
in the analysis results in a less significant P value as-
sociated with that LOD score. As a result, the two LOD
scores for D21S1260 have virtually equivalent P values
( , homogeneity, vs. , heteroge-P ! .000183 P ! .000156
neity). Map distances listed correspond to the genetic
distance from the p-terminus of chromosome 21 and are
taken or derived from the Marshfield Genetics map.
In lieu of multipoint linkage analyses, which are highly
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Table 1
Two-Point LOD Score Analysis
CM MARKER
LOD SCORE
Homogeneity Heterogeneity
2.99 D21S1432 .00 .44
13.05 D21S1437 .00 .01
17.67 D21S1409 .00 .00
23.34 D21S1435 .00 .00
27.4 D21S1270 .16 .16
29.4 D21S262 .08 .08
29.78 D21S1413 .00 .00
31.26 D21S1254 .01 .01
33.84 D21S1895 .36 .36
35.45 D21S1252 .34 .34
36.77 D21S1440 .59 .59
D21S1290 .18 .28
39.22 D21S1255 .83 .92
40.45 D21S168 .74 .85
40.47 D21S1412 .00 .00
40.49 D21S268 .00 .19
40.49 D21S2055 .16 .17
43.67 D21S1893 .00 .00
45.55 D21S231 .00 .39
45.87 D21S1906 1.14 1.14
45.87 D21S1887 1.30 1.30
45.87 D21S266 1.27 1.39
46.71 D21S1260 2.76 3.35
51.49 D21S1411 .00 .11
PFKL .33 .34
52.5 D21S1890 .00 .00
52.5 D21S1885 .00 .09
53.05 D21S1912 .00 .01
54.22 D21S1897 .47 .47
D21S1809 .57 .60
57.77 D21S1446 .00 .01
Table 2
Polylocus Linkage Analysis
Marker PL-Hom PL-Het
D21S1906 1.23 1.23
D21S1887 1.41 1.41
D21S266 1.20 1.33
D21S1260 2.61 3.25
NOTE.—PL-Hom polylocus linkage un-
der the assumption of homogeneity; PL-Het
 polylocus linkage under the assumption
of heterogeneity.
dependent on accurate estimates of intermarker recom-
bination fractions, marker allele frequencies, and precise
marker ordering, polylocus linkage analysis was per-
formed. Table 2 shows the results of polylocus analysis,
with four markers calculated in the context of each in-
dividual marker location. Polylocus analysis under the
assumption of genetic heterogeneity had little effect on
the LOD scores, with a at D21S1260 (tableZ  3.25max
2).
In this study, we genotyped 12 of the 45 individuals
available from family 01001, consistent with the selec-
tion procedure described in Material and Methods. We
included 8 of the 9 affecteds under diagnostic model III
(the ninth individual was accidentally omitted because
of a clerical error during the selection of samples for
genotyping). In a two-point pseudomarker analysis of
this family, D21S1260 gave a LOD score of 0.41. Anal-
ysis of the pedigree set after the removal of family 01001
gave a two-point heterogeneity LOD score of 3.07 at
D21S1260 (table 3).
We compared the analytical models used here with
those of Straub et al. (1994), using data from the PFKL
locus (the only marker shared between the two studies).
In the present study, family 01001 gave a LOD score of
0.67. Examination of the same data using the analytical
methods of Straub et al. (1994) gave a LOD score of
0.70. Inclusion of the ninth affected individual, who was
inadvertently excluded from this pedigree (see above),
would have resulted in LOD scores of 0.95 and 0.94,
respectively.
Two-point pseudomarker analysis of other diagnostic
models, under both dominant and recessive inheritance,
produced no significant results (data not shown). In ad-
dition, after all pedigrees were divided into their com-
ponent nuclear families, affected sib pair analysis and
pseudomarker analysis were performed, with no signif-
icant findings (data not shown). Table 4 provides infor-
mation on the heterozygosity and PIC of the markers
we used, as estimated from the individuals in this study.
Discussion
Our recent genome scan for linkage to BP (J. Liu, V.
M. Aita, J. Terwilliger, T. C. Gilliam, and M. Baron,
unpublished data) provides a frame of reference for the
interpretation of this report. The subset of samples gen-
otyped and the linkage methods are identical in both
studies; this allows for a direct comparison of LOD
scores. This comparison reveals that the highest ho-
mogeneity LOD score in this study ( atZ  2.76max
D21S1260; table 1) ranks as the highest (whole pedigree)
homogeneity LOD score found across all diagnostic
models tested in our genome scan to date. This obser-
vation, coupled with the findings noted earlier (see In-
troduction and Results), is consistent with the hypothesis
that 21q22 harbors a vulnerability locus for BP.
This report expands on our previous study (Straub et
al. 1994) in that it is based on a denser marker coverage
of 21q22 in the entire pedigree series selected for ge-
notyping, without deference to any one particular family.
Although family 01001—the family that provided the
strongest support for linkage in our previous re-
port—was included in this sample set, only 12 of the 45
individuals available for genotyping were studied. Our
results suggest that the linkage evidence in the current
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Table 3
Two-Point LOD Scores (Family 01001
Excluded)
MARKER
LOD SCORE
Homogeneity Heterogeneity
D21S1906 .97 .97
D21S1887 1.24 1.24
D21S266 1.45 1.53
D21S1260 2.24 3.07
D21S1411 .01 .15
PFKL .24 .25
Table 4
Marker Heterozygosity and PIC
Marker Heterozygosity
Polymorphism
Information Content
D21S1432 .70 .65
D21S1437 .77 .74
D21S1409 .73 .69
D21S1435 .74 .71
D21S1270 .76 .74
D21S262 .76 .73
D21S1413 .72 .67
D21S1254 .57 .50
D21S1895 .86 .85
D21S1252 .85 .83
D21S1440 .71 .66
D21S1290 .78 .76
D21S1255 .83 .80
D21S168 .76 .73
D21S1412 .85 .84
D21S268 .88 .87
D21S2055 .89 .88
D21S1893 .76 .72
D21S231 .61 .57
D21S1906 .52 .46
D21S1887 .74 .70
D21S266 .60 .58
D21S1260 .80 .78
D21S1411 .88 .87
PFKL .64 .60
D21S1890 .89 .88
D21S1885 .65 .62
D21S1912 .80 .78
D21S1897 .67 .63
D21S1809 .67 .62
D21S1446 .79 .77
study comes from the entire pedigree series rather than
just this previously identified family. Specifically, at our
most “significant” marker, D21S1260, the removal of
family 01001 still results in a two-point heterogeneity
LOD score of 3.07 (table 3).
As shown above, when we recomputed LOD scores
for family 01001 from the Straub et al. (1994) article,
using only the 12 people chosen for genotyping in the
current study, the results for PFKL (the only marker used
in both studies) were nearly identical: 0.70 with the
methods of Straub et al. (1994) versus 0.67 in the current
study. This suggests that the reduced LOD scores in this
family—0.67 (or 0.95, if the missing individual is added;
see Results) versus 3.41 (Straub et al. 1994)—are likely
the result of fewer persons genotyped (12 vs. 45 in
Straub et al. 1994) rather than different analytical mod-
els in the two studies.
Of interest, the results from our genome scan (J. Liu,
V. M. Aita, J. Terwilliger, T. C. Gilliam, and M. Baron,
unpublished data) do not corroborate the evidence for
linkage to 21q22. However, the marker spacing over the
entire genome averaged 10 cM (compared with !2 cM
in the present study), and the marker nearest to
D21S1260 (the locus with the peak LOD score in the
present study) was ∼8 cM away. This serves as an im-
portant caveat to the interpretation of results from ge-
nome scans—in particular, overconfidence in the marker
coverage reported for linkage to complex diseases. Ran-
dom fluctuations in marker informativeness in any given
family across a pedigree series could result in errors in
linkage detection.
In designing this study, we used an “affecteds-only”
approach. This ensured that all results were derived un-
der the assumption that affecteds have similar genotypes
at the disease locus, whereas no assumptions are made
about disease-locus genotypes of the unaffecteds. The
approach, therefore, does not require the interpretation
that unaffected individuals do not carry alleles involved
in predisposition to BP. Given the complexities of clinical
diagnosis of this phenotype, this approach seemed pru-
dent. In addition, choosing only affected individuals and
critical connecting persons for genotyping is a cost-ef-
fective way of investigating a sample set as large as this
one. Elimination of founders and married-in spouses
maximizes the power per genotype in an analysis but
could lead to a higher type I error rate (Holmans and
Craddock 1997). In addition, genotyping errors could
be less detectable without the genotyping of married-in
spouses, and this could lead to additional errors. In the
current study, the genotyping data were checked for
Mendelization errors, and intermarker recombination
rates were consistent with published genetic maps.
In an attempt to extract the maximal linkage infor-
mation from a given region containing multiple markers,
researchers often supplement two-point linkage methods
with multipoint analyses. At extremely close marker
spacing, however, multipoint analyses often become
more difficult to perform because currently reported ge-
netic map distances !2 cM are only tentatively resolved
and cannot be estimated more accurately without
thousands of informative meioses. Alternatively, poly-
locus linkage analysis combines data from multiple
linked loci into one “superlocus,” which increases the
power of the analysis by increasing the number of in-
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formative meioses in a given pedigree series (Terwilliger
and Ott 1993). As noted above, our polylocus results
are consistent with the results of the two-point pseu-
domarker analysis (table 2).
Although our use of several analytical models en-
hanced the prospects of detecting true linkage, it also
increased the chances of a false-positive finding. How-
ever, the prior evidence of linkage to 21q22 and the fact
that some of these tests are correlated—for example,
there is some overlap in disease definitions (diagnostic
model I is nested in model II, and model II is nested in
model III), and recessive inheritance models mimic re-
sults from affected sibpair analysis—serve to offset the
inflationary impact of multiple testing on our finding.
In addition, the highest LOD scores reported here were
obtained with the same phenotypic model (diagnostic
model III) and mode of inheritance (dominant) reported
in our previous study (Straub et al. 1994). This provides
a measure of confidence in the current results. Although
the exact mode of inheritance for BP is unknown, some
studies advocate a role for dominant transmission (Rice
et al. 1987; Spence et al. 1995). Our pedigrees show
primarily a “dominant-like” pattern—our ascertainment
plan sought families with unilineal transmission (Baron
et al. 1994)—and our genotyping strategies were opti-
mized accordingly (see Material and Methods).
Identification of possible candidate genes for the BP
locus implicated on chromosome 21q22 is greatly fa-
cilitated by the fortuitous colocalization of this region
with the Down syndrome critical region (DCR) (Peter-
son et al. 1994; Osoegawa et al. 1996; Ohira et al. 1997).
Our linkage analyses maximize at a marker within 3–5
cM of the DCR. Given the difficulty with pinpointing
specific intervals implicated in linkage studies of complex
traits and the further proximal linkage finding of Detera-
Wadleigh (1996, 1997), consideration of the DCR is
warranted. Figure 1 provides a graphical representation
of LOD scores in this report, as well as relative map
positions of other reported BP findings on 21q and the
DCR. Several authors have even suggested that the im-
plication of this region in both disorders may be bio-
logically relevant and that some of the same genes may
be involved in both disorders (reviewed by Craddock
and Owen 1994). Extensive physical mapping of the
DCR using YACs, phage artificial chromosomes, and
cosmids has been described (Dufresne-Zacharia et al.
1994; Osoegawa et al. 1996), and sequencing of the
region is currently underway as part of the Human Ge-
nome Project. Detailed transcript maps of the region
have been generated by a variety of methods, including
cDNA selection (Dahmane et al. 1998), exon trapping
(Ohira et al. 1997), and alu-splice PCR (Fuentes et al.
1997).
To investigate the role of specific genes in this region,
Smith et al. (1997) generated a 2-Mb in vivo library of
large-insert transgenic mice from human chromosome
21q22. They further used this library to identify one
specific human gene (DYRK), the human homologue of
the Drosophila minibrain gene, that is responsible for
learning defects in mice and possibly the learning defects
associated with Down syndrome (reviewed by Smith and
Rubin 1997). Other animal models, including both gain-
and loss-of-function transgenic mice, have been gener-
ated for a number of genes on distal chromosome 21,
although none are thought to model exactly any of the
disorders associated with this chromosome (reviewed by
Kola and Hertzog 1997).
In addition to the DCR, an integrated physical and
transcript map of 2.5 Mb of 21q22.3 has been described
(Lapenta et al. 1998). That report precisely positions 13
genes and 4 expressed sequence tags, including PFKL
(fig. 1f). Collectively, to date, extensive physical and
transcript map data have been reported for at least 6–7
Mb of 21q22.
In summary, chromosome 21q22 is one of the most
extensively studied regions in the human genome. This
should greatly enhance the search for candidate disease
genes, including the putative BP locus, in this region.
Our results, together with previous data supporting link-
age of BP to 21q22, may justify such an effort.
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